榮陽實業(02078.HK)預計年度股東應占虧損大幅收窄
格隆匯2月6日丨榮陽實業(02078.HK)公佈,預期集團於截至2022年12月31日止年度將會錄得股東應占虧損約9740萬港元,而截至2021年12月31日止年度則錄得股東應占虧損約3.407億港元。
董事會認為,預期截至2022年12月31日止年度之股東應占虧損將會較截至2021年12月31日止年度有所減少,主要乃由於以下各項所致:(i)毛利率持續改善;(ii)有關集團於澳洲之經營業務的海關退款增加;(iii)貿易應收款項減值虧損轉回;(iv)銷售開支減少,其被以下各項所抵銷:(v)確認投資物業公允價值虧損;及(vi)確認物業、廠房及設備減值虧損。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.